The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function

By sjmartinez • February 15, 2023

Vergara N, de Mier MVP, Rodelo-Haad C, Revilla-González G, Membrives C, Díaz-Tocados JM, Martínez-Moreno JM, Torralbo AI, Herencia C, Rodríguez-Ortiz ME, López-Baltanás R, Richards WG, Felsenfeld A, Almadén Y, Martin-Malo A, Ureña J, Santamaría R, Soriano S, Rodríguez M, Muñoz-Castañeda JR. The direct effect of fibroblast growth factor 23 on vascular smooth muscle cell phenotype and function. Nephrol Dial Transplant. 2023 Feb 13;38(2):322-343. doi: 10.1093/ndt/gfac220. PMID: 35867864; PMCID: PMC9923714.

Tags: arterial stiffness, Chronic kidney disease, FGF23, microRNA, Nephrology, Publications, vascular smooth muscle cells

Artificial intelligence in medicine and nephrology: hope, hype, and reality

Glassock RJ. Artificial intelligence in medicine and nephrology: hope, hype, and reality. Clin Kidney J. 2024 Mar 22;17(4):sfae074. doi: 10.1093/ckj/sfae074. PMID: 38618490; PMCID: PMC11015150.

Prognostic Scoring in IgA Vasculitis

Glassock RJ. Prognostic Scoring in IgA Vasculitis. Clin J Am Soc Nephrol. 2024 Apr 1;19(4):409-411. doi: 10.2215/CJN.0000000000000444. PMID: 38598194.

Elevation of Donor-derived Cell-free DNA Before Biopsy-proven Rejection in Kidney Transplant

Bromberg JS, Bunnapradist S, Samaniego-Picota M, Anand S, Stites E, Gauthier P, Demko Z, Prewett A, Armer-Cabral M, Marshall K, Kaur N, Bloom MS, Tabriziani[...]